Matinas BioPharma Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leasehold Improvements and Equipment

Leasehold Improvements and Equipment

9 Months Ended

Sep. 30, 2024

Property, Plant and Equipment [Abstract]

Note 6 – Leasehold Improvements and Equipment

Leasehold improvements and equipment, summarized by major category, consist of the following as of September 30, 2024 and December 31, 2023:

	September 30, 2024		December 31, 2023
Equipment	$	2,463	$	2,463
Leasehold improvements		1,155		1,155
Total		3,618		3,618
Leasehold improvements and equipment, gross		3,618		3,618

Less: accumulated depreciation and amortization		1,970		1,695
Leasehold improvements and equipment, net	$	1,648	$	1,923

Depreciation and amortization expense for the three and nine months ended September 30, 2024 was $90 and $275, respectively, and the three and nine months ended September 30, 2023 were $98 and $288, respectively. During the nine month periods ended September 30, 2023, the Company purchased equipment of $218. The Company did not purchase any equipment during the nine months ended September 30, 2024.